A
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Jul 2020)
What this means for you
This application is over — abandoned 13 Jul 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87477062
- Mark type
- Design + words
- Filed
- 06 Jun 2017
- Published for opposition
- 17 Oct 2017
- Abandoned
- 13 Jul 2020
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of hypertension, depression, cardiovascular disease, allergies, neurological disorders, gastro-intestinal disease, urinary incontinence, Parkinson's disease, Alzheimer's disease, oncology, diabetes and metabolic disorders, dermatological disorders, bipolar disorder and schizophrenia, vitamin D deficiency, bleeding disorders, women's health, BPH or benign prostatic hyperplasia, erectile dysfunction and pain
Owner
- Amerigen Pharmaceuticals, Ltd., KY1-1111, KY
- Amerigen Pharmaceuticals, Ltd., KY1-1111, KY
Prosecution history
- 13 Jul 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Jul 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Jan 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 20 Nov 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2019 — SOU EXTENSION 4 GRANTED
- 18 Nov 2019 — SOU EXTENSION 4 FILED
- 18 Nov 2019 — SOU TEAS EXTENSION RECEIVED
- 12 Jun 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jun 2019 — SOU EXTENSION 3 GRANTED
- 10 Jun 2019 — SOU EXTENSION 3 FILED
- 10 Jun 2019 — SOU TEAS EXTENSION RECEIVED
- 14 Dec 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2018 — SOU EXTENSION 2 GRANTED
- 12 Dec 2018 — SOU EXTENSION 2 FILED
- 12 Dec 2018 — SOU TEAS EXTENSION RECEIVED